Benefits
Type 2 Diabetes Glycemic Control (24-Week RCT)
DeltaGold 250 mg/day for 24 weeks in 110 T2DM patients showed significant improvements in fasting blood glucose, HbA1c, insulin, HOMA-IR, plus reduced inflammation and oxidative stress markers (Phytotherapy Research 2021).
Cardiovascular Health
Multiple DeltaGold trials demonstrate cholesterol management (7-8% LDL reduction in T2DM trial), reduced inflammation, oxidative stress reduction.
Metabolic Syndrome
Delta- and gamma-tocotrienols more effective than alpha-tocotrienol/tocopherol at attenuating metabolic syndrome — established in multiple studies.
Bone Health (Postmenopausal Women)
Annatto tocotrienol shows promise as bone health promoter in postmenopausal women — published clinical evidence.
TOCOPHEROL-FREE Distinction
Critical — alpha-tocopherol interferes with tocotrienol uptake and function; DeltaGold is tocopherol-free unlike palm/rice tocotrienols (which contain interfering alpha-tocopherol).
FDA GRAS Status
First tocopherol-free tocotrienol product to receive FDA GRAS — enables food and beverage applications.
Patent-Protected US Manufacturing
Patented manufacturing process; US-based production.
Triglyceride Reduction
T2DM trial showed 10.3% triglyceride reduction with DeltaGold vs 0.9% placebo.
Mechanism of action
Delta- and Gamma-Tocotrienol Activity
Smaller chromanol head structure than alpha-T3 enables greater cell membrane penetration and stronger potency; superior to alpha forms in most metabolic applications.
HMG-CoA Reductase Modulation
Tocotrienols inhibit HMG-CoA reductase (cholesterol synthesis enzyme) — different mechanism than statins; cholesterol-lowering effects.
miRNA Modulation (T2DM Trial)
T2DM trial demonstrated 2-3-fold modifications in microRNAs associated with diabetes, inflammation, oxidative stress — sophisticated regulatory mechanism.
NF-kB Anti-Inflammatory
Delta- and gamma-T3 modulate NF-kB inflammatory pathway; reduce IL-6, TNF-alpha (15.9% and 13.7% reductions in T2DM trial).
Antioxidant Activity
Tocotrienols have superior free radical scavenging vs tocopherols due to unsaturated side chain enabling more efficient tissue incorporation.
No Interference from Alpha-Tocopherol
DeltaGold's tocopherol-free composition prevents alpha-tocopherol's interference with tocotrienol uptake and function.
Clinical trials
24-week randomized double-blind placebo-controlled trial of 250 mg/day DeltaGold in 110 T2DM patients.
110 patients with type 2 diabetes mellitus.
Significant improvements in fasting blood glucose, HbA1c, insulin, HOMA-IR. Triglycerides reduced 10.3% (vs 0.9% placebo). LDL cholesterol reduced 8.5%. IL-6 reduced 15.9%, TNF-alpha 13.7%. miRNA modulation. Confirmed first-in-class tocotrienol diabetes management.
Clinical study of annatto tocotrienol on bone markers in postmenopausal women.
Postmenopausal women.
Promising bone health promoter; supports healthy aging applications.
Multiple DeltaGold trials on cardiovascular and inflammatory markers.
Various populations including cardiovascular and metabolic concerns.
Lipid parameter improvements; reduced inflammatory biomarkers.
About this ingredient
DELTAGOLD is the FIRST AND ONLY TOCOPHEROL-FREE TOCOTRIENOL ingredient — from AMERICAN RIVER NUTRITION (Hadley, Massachusetts; Everwell Health subsidiary; founded 1998 by DR. BARRIE TAN — pioneering tocotrienol scientist who identified annatto as primary plant tocotrienol source). ANNATTO BACKGROUND: Bixa orellana — rainforest plant; carotenoid-producing; rapid photo-oxidation protection in carotenoids identified tocotrienol presence; nearly 100% tocotrienol producer (vs rice/palm which produce significant alpha-tocopherol).
KEY DISTINCTIONS: (1) ONLY TOCOPHEROL-FREE tocotrienol commercially available; (2) ~90% DELTA + 10% GAMMA composition; (3) FDA GRAS status (first tocopherol-free tocotrienol with GRAS); (4) Patent-protected US manufacturing; (5) Multiple peer-reviewed RCTs including 110-patient T2DM trial; (6) Dr. Barrie Tan's pioneering scientific contribution; (7) Dual cardiovascular AND metabolic AND bone health evidence.
EVIDENCE-BASED USES: (1) Type 2 diabetes glycemic control; (2) Cardiovascular health (lipids, inflammation); (3) Metabolic syndrome; (4) Bone health (postmenopausal); (5) Anti-inflammatory; (6) Antioxidant; (7) Healthy aging.
CRITICAL CAUTIONS: (1) ALPHA-TOCOPHEROL INTERFERENCE — established 1996+ research shows alpha-tocopherol interferes with tocotrienol uptake/function; DeltaGold's tocopherol-free composition critical for benefits; AVOID combining with high-dose alpha-tocopherol supplements; (2) PALM/RICE TOCOTRIENOLS — contain 23%+ alpha-tocopherol; significantly reduce tocotrienol benefits; DeltaGold superior; (3) DOSE — 125-300 mg/day; T2DM trial used 250 mg; (4) DURATION — effects build over weeks-months; T2DM trial 24 weeks; (5) DIABETES MEDICATIONS — additive glycemic effects; monitor; (6) STATINS — additive cholesterol-lowering; complementary; (7) ANTICOAGULANTS — modest effects; (8) PRE-SURGERY — discontinue 1-2 weeks; (9) PREGNANCY/LACTATION — limited specific data; (10) DELTAGOLD vs MIXED TOCOPHEROLS (Cargill) — completely different vitamin E family components; tocotrienols emerging as superior to tocopherols for many applications; (11) FOR COMPREHENSIVE METABOLIC HEALTH — diet, exercise, weight management, possibly medications, supplements adjunct; (12) BRAND VERIFICATION — DeltaGold is American River Nutrition trademark; tocopherol-free annatto tocotrienol; (13) Among the most premium and well-evidenced tocotrienol ingredients globally.